Statin adherence in primary care among patients with hypertension with and without other cardiometabolic diseases

Back

ESC2025 Premium Access

Statin adherence in primary care among patients with hypertension with and without other cardiometabolic diseases

Session: Changing face of lipid-lowering therapy

Topic: Drug therapy

Speaker: Doctor J. Sandslatt (Gothenburg, SE)

Event: ESC Congress 2025

Congress Presentation

Add to my library

About the speaker

Doctor Johan Sandslatt

Institute of Medicine - Sahlgrenska Academy - University of Gothenburg, Gothenburg (Sweden)

0 follower

5 more presentations in this session

Temporal trends in lipid-lowering therapy utilization among ASCVD patients: a large-scale database analysis

Speaker: Doctor M. Goldberg (Tel Aviv, IL)

Predictors of lipid-lowering therapy intensification over 1 year of prospective follow-up in Europe: insights from the SANTORINI study

Speaker: Doctor C. Aguiar (Lisbon, PT)

Real-world prescribing patterns for lipid-lowering therapy in high cardiovascular risk patients in germany: a cross-sectional analysis

Speaker: Professor O. Weingaertner (Jena, DE)

Oral PCSK9 inhibitors as an emerging frontier in lipid management: a meta-analysis

Speaker: Mr V. Ho (Debrecen, HU)

Efficacy of obicetrapib across the spectrum of background lipid lowering therapies-pooled analyses of the Broadway and Brooklyn randomised trials

Speaker: Professor K. Ray (London, GB)

Access the full session

Changing face of lipid-lowering therapy

Speakers: Doctor J. Sandslatt, Doctor M. Goldberg, Doctor C. Aguiar, Professor O. Weingaertner, Mr V. Ho...

Access

Video

About the event

ESC Congress 2025

29 August - 1 September 2025

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources